Albireo Pharma Inc Insider ownership
What is the Insider ownership of Albireo Pharma Inc?
The Insider ownership of Albireo Pharma Inc is 0.48%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to Albireo Pharma Inc
What does Albireo Pharma Inc do?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
Companies with insider ownership similar to Albireo Pharma Inc
- The Interpublic of Companies has Insider ownership of 0.48%
- Brookfield Business has Insider ownership of 0.48%
- New Residential Investment Corp has Insider ownership of 0.48%
- Qorvo Dl ,0001 has Insider ownership of 0.48%
- Qorvo Inc has Insider ownership of 0.48%
- Definity has Insider ownership of 0.48%
- Albireo Pharma Inc has Insider ownership of 0.48%
- EQT has Insider ownership of 0.48%
- Northern 2 VCT PLC has Insider ownership of 0.49%
- Ascot Resources has Insider ownership of 0.49%
- Ascot Resources has Insider ownership of 0.49%
- Olin has Insider ownership of 0.49%
- Editas Medicine Inc has Insider ownership of 0.49%